Prediction of incident diabetes mellitus by baseline IGF1 levels

European Journal of Endocrinology

Volumn 164, Issue 2, 2011, Pages 223-229

  Schneider, Harald Jörn ^a   Friedrich, Nele ^b   Klotsche, Jens ^c   Schipf, Sabine ^b   Nauck, Matthias ^b   Völzke, Henry ^b   Sievers, Caroline ^d   Pieper, Lars ^c   März, Winfried ^e   Wittchen, Hans Ulrich ^c   Stalla, Günter Karl ^d   Wallaschofski, Henri ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; ADULT; INTERMETHOD COMPARISON; METABOLIC PARAMETERS; PREDICTION; PROTEIN FUNCTION; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78751500851     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0963     Document Type: Article

References (26)

1. Stern MP, Williams K & Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Annals of Internal Medicine 2002 136 575-581.
2. Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M & Koenig W. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg Cohort Study, 1984-1998. Archives of Internal Medicine 2003 163 93-99. (doi:10.1001/archinte. 163.1.93)
3. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, Pfeiffer AF, Spranger J, Thamer C, Häring HU, Fritsche A & Joost HG. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007 30 510-515. (doi:10.2337/dc06-2089) (Pubitemid 46354326)
4. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM & D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Archives of Internal Medicine 2007 167 1068-1074. (doi:10.1001/archinte.167.10.1068) (Pubitemid 46835795)
5. Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Kaplan RC, Muzumdar R, Rohan TE & Strickler HD. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes/Metabolism Research and Reviews 2009 25 3-12. (doi:10.1002/dmrr.919)
6. Ezzat VA, Duncan ER, Wheatcroft SB & Kearney MT. The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease. Diabetes, Obesity and Metabolism 2008 10 198-211. (doi:10.1111/j.1463-1326.2007.00709.x)
7. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB & Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745. (doi:10.1016/S0140-6736(02)08655-5)
8. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA & van Duijn CM. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001 50 637-642. (doi:10.2337/diabetes.50.3.637)
9. van der Klaauw AA, Biermasz NR, Feskens EJ, Bos MB, Smit JW, Roelfsema F, Corssmit EP, Pijl H, Romijn JA & Pereira AM. The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. European Journal of Endocrinology 2007 156 455-462. (doi:10.1530/EJE-06-0699)
10. Melmed S. Medical progress: acromegaly. New England Journal of Medicine 2006 355 2558-2573. (doi:10.1056/NEJMra062453)
11. Schneider HJ, Klotsche J, Saller B, Lehnert H, Böhler S, Sievers C, Pittrow D, Ruf G, März W, Erwa W, Zeiher AM, Silber S, Wittchen HU & Stalla GK. Associations of age-dependent insulin-like growth factor-1 standard deviation scores to diseases and risk conditions: cross-sectional study in 6,282 primary care patients. European Journal of Endocrinology 2008 158 153-161. (doi:10.1530/EJE-07-0600)
12. Wittchen HU, Glaesmer H, März W, Stalla GK, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow D & Ruf G. Cardiovascular risk factors in primary care:methods and baseline prevalence rates - the DETECT program. Current Medical Research and Opinion 2005 21 619-629. (doi:10.1185/030079905X38187) (Pubitemid 40676115)
13. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S & Kessler C. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Social and Preventive Medicine 2001 46 186-194. (doi:10.1007/BF01324255)
14. Friedrich N, Haring R, Nauck M, Lüdemann J, Rosskopf D, Spilcke- Liss E, Felix SB, Dörr M, Brabant G, Völzke H & Wallaschofski H. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. Journal of Clinical Endocrinology and Metabolism 2009 94 1732-1739. (doi:10.1210/jc.2008-2138)
15. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009 32 1327-1334. (doi:10.2337/dc09-9033)
16. Singer JD &Willett JB. It's about time: using discrete-time survival analysis to study duration and the timing of events. Journal of Educational Statistics 1993 18 155-195. (doi:10.2307/1165085)
17. Clayton D & Hills M. Statistical Models in Epidemiology, pp 1-375 Oxford: Oxford University Press, 1993.
18. Royall RM. Model robust confidence intervals using maximum likelihood estimators. International Statistical Review 1986 54 221-226. (doi:10.2307/1403146)
19. Grennland S & Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985 41 55-68. (doi:10.2307/2530643)
20. Edén Engström B, Burman P, Holdstock C, Ohrvall M, Sundbom M & Karlsson FA. Effects of gastric bypass on the GH/IGF-I axis in severe obesity - and a comparison with GH deficiency. European Journal of Endocrinology 2006 154 53-59. (doi:10.1530/eje.1.02069) (Pubitemid 43250736)
21. Arafat AM,Weickert MO, Frystyk J, Spranger J, Schöfl C, Möhlig M & Pfeiffer AF. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. Journal of Clinical Endocrinology and Metabolism 2009 94 5093-5101. (doi:10.1210/jc.2009- 0875)
22. Møller N & Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews 2009 30 152-177. (doi:10.1210/er.2008-0027)
23. Robertson K, Lu Y, De Jesus K, Li B, Su Q, Lund PK & Liu JL. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. American Journal of Physiology. Endocrinology and Metabolism 2008 294 E928-E938. (doi:10.1152/ajpendo.00606.2007)
24. Olsson B, Bohlooly-Y M, Fitzgerald SM, Frick F, Ljungberg A, Ahrén B, Törnell J, Bergström G & Oscarsson J. Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 2005 146 920-930. (doi:10.1210/en.2004-1232)
25. Schneider HJ, Sievers C, Saller B, Wittchen HU & Stalla GK. High prevalence of biochemical acromegaly in primary care patients with elevated insulin-like growth factor-1 levels. Clinical Endocrinology 2008 69 432-435. (doi:10.1111/j.1365-2265.2008.03221.x)
26. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD & Ben-Shlomo Y. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 2002 51 2313-2316. (doi:10.2337/diabetes.51.7.2313)